An Open-Label Trial of Granulocyte Macrophage Colony Stimulating Factor Therapy for Moderate Symptomatic Pulmonary Alveolar Proteinosis
- 1 July 2006
- Vol. 130 (1) , 227-237
- https://doi.org/10.1378/chest.130.1.227
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The benefits of whole lung lavage in pulmonary alveolar proteinosisEuropean Respiratory Journal, 2004
- Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Pulmonary Alveolar Proteinosis Is a Disease of Decreased Availability of GM-CSF Rather than an Intrinsic Cellular DefectClinical Immunology, 2000
- Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating FactorThe Journal of Experimental Medicine, 1999
- Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 β c receptor-deficient mice despite correction of alveolar proteinosis after BMTBone Marrow Transplantation, 1997
- Efficacy of Granulocyte–Macrophage Colony-Stimulating Factor in Acquired Alveolar ProteinosisNew England Journal of Medicine, 1996
- The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation.The Journal of Experimental Medicine, 1996
- Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice.Journal of Clinical Investigation, 1996
- Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.Proceedings of the National Academy of Sciences, 1994
- Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary HomeostasisScience, 1994